Jimmy Leung

Partner, 28 Ventures

📍 Japan🔄 Updated September 2026💼 7 investments📅 8 years investing🗓 Last invested Oct 2023
VC🌍 Japan
7
Total investments
3
Early stage
2
Mid stage
1
Late stage
8y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Oct 2023
Aether Holdings, Inc. (Nasdaq: ATHR) is an emerging financial technology holding company focused on transforming the way investors navigate the markets. Leveraging decades of market expertise and cutting-edge technology, Aether delivers proprietary tools, data, and research to empower traders with actionable insights and enhanced decision-making capabilities.
Investor
Feb 2023
Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors.
Investor
Jun 2021
UpMeals is a team of professional chefs, nutritionists and designers. Were a food technology company that empowers organizations to provide healthy, branded food solutions to their customers or employees.
Investor
Jan 2021
Patreon is the best place for creators to build community with their biggest fans, share exclusive work, and turn their passions into lasting creative businesses. Hundreds of thousands of video creators, podcasters, musicians, writers, game developers, and more are achieving creative and financial freedom doing what they love on Patreon, powered directly by fans who love what they do. Our endgame? A future where creators are in control, and real community thrives.
Investor
Oct 2020
BevCanna offers investors an early-stage opportunity to invest in the emerging cannabis beverage market. Our unmatched expertise, world-class infrastructure and proven technology enable us to develop and launch premium, innovative, cannabinoid-infused beverages that cater to the next generation of cannabis consumer. We are building a lasting business committed to long-term results. Our business is focused on innovation. We produce infused beverages and launch dynamic brands while actively exploring new brand acquisitions, strategic partnerships and joint venture opportunities.
Investor
Jan 2018
mid stageManufacturing
Experience · 9 entries
All (9)
Investments (7)
2023
Partner
Oct 2023
We are not defined by a specific industry or sector. We seek for companies that could drive positive global impact. We invest and we work. We allow companies to leverage on our expertise and global network to support growth to maximize shareholders value. Our strategy is opportunistic and is stage, sector and location agnostic.
Investor
Oct 2023
At SentimenTrader.com, our focus is not market timing per se, but rather risk management. That may be a distinction without a difference, but its how we approach the markets. We study signs that suggest it is time to raise or lower market exposure as a function of risk relative to probable reward. It is all about risk-adjusted expectations given existing evidence. Published by Sundial Capital Research.
Investor
Oct 2023
Aether Holdings, Inc. (Nasdaq: ATHR) is an emerging financial technology holding company focused on transforming the way investors navigate the markets. Leveraging decades of market expertise and cutting-edge technology, Aether delivers proprietary tools, data, and research to empower traders with actionable insights and enhanced decision-making capabilities.
Investor
Feb 2023
Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency in the public sector. CytoMed is a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors.
2021
Investor
Jun 2021
UpMeals is a team of professional chefs, nutritionists and designers. Were a food technology company that empowers organizations to provide healthy, branded food solutions to their customers or employees.
Show all 9 entries ↓
Investment activity
2018–2023 · 7 investments
20181202012021220233
Recent (last 2 years)Earlier